Influence of Hydrophobic and Hydrophilic Chain Length of CiEj Surfactants on the Solubilization of Active Pharmaceutical Ingredients.

Up to 90% of all newly developed active pharmaceutical ingredients (APIs) are poorly water soluble, most likely also showing a low oral bioavailability. In order to increase the aqueous solubility of these APIs, surfactants are promising excipients to increase both solubility and consequently bioavailability (e.g., in lipid- and surfactant-based drug delivery systems). In this work, we investigated the influence of hydrophobic and hydrophilic chain lengths of CiEj surfactants (C8E6, C10E6, and C10E8) toward the solubilization of fenofibrate, naproxen, and lidocaine. Furthermore, we investigated the partitioning of these APIs between the surfactant aggregates and the surrounding aqueous bulk phase. For all APIs considered, we determined the locus of API solubilization as well as the individual aggregation numbers (Nagg) of surfactants and API molecules in an API/surfactant aggregate. We further determined the hydrodynamic radius (Rh) of the API/surfactant aggregates in the absence and presence of the APIs. The size of the API/surfactant aggregates (Nagg, Rh) passes through a minimum upon lidocaine solubilization; it gradually increases upon naproxen solubilization and is almost constant upon fenofibrate solubilization. The results give valuable insights into the solubilization mechanisms of APIs in the CiEj surfactant aggregates. Our results reveal that fenofibrate is solely solubilized in the hydrophobic core of the CiEj surfactant aggregates, as only the hydrophobic chain length of the surfactant influences its solubilization. Naproxen is solubilized in the palisade layer of the surfactant aggregates, as both the hydrophobic and hydrophilic chain lengths are decisive for its solubilization. Lidocaine is mainly solubilized in the rather hydrophilic corona region of the surfactant aggregates, as the hydrophilic chain length of the surfactant governs its solubilization. The results further reveal that the hydrophilic/lipophilic balance is not an appropriate measure to estimate the solubilization capacity of surfactant aggregates.

Electrodes for Membrane Surface Science. Bilayer Lipid Membranes Tethered by Commercial Surfactants on Electrochemical Sensors.

Commercial surfactants, which are inexpensive and abundant, were covalently grafted to flat and transparent electrodes, and it appears to be a simple functionalization route to design biomembrane sensors at large-scale production. Sparsely tethered bilayer lipid membranes (stBLM) were stabilized using such molecular coatings composed of diluted anchor-harpoon surfactants that grab the membrane with an alkyl chain out of a PEGylated-hydrogel layer, which acts as a soft hydration cushion. The goal of avoiding the synthesis of complex organic molecules to scale up sensors was achieved here by grafting nonionic diblock oligomers (Brij58 = C xH2 x+1(OCH2CH2) nOH with x = 16 and n = 23) and PEO short chains ((OCH2CH2) nOH with n = 9 and n = 23) from their hydroxyl (-OH) end-moiety to a monolayer of -Ar-SO2Cl groups, which are easy to form on electrodes (metals, semiconducting materials, ...) from aryl-diazonium salt reduction. A hybrid molecular coating on gold, with scarce Ar-SO2-Brij58 and PEO oligomers, was used to monitor immobilization and fusion kinetics of DOPC small unilamellar vesicles (SUV) by both quartz crystal microbalance (QCM) and surface plasmon resonance (SPR) techniques. Using flat and transparent thin chromium film electrodes, we designed biosensors to couple surface sensitive techniques for membranes, including X-ray reflectivity (XRR), atomic force microscopy (AFM) with subnanometer resolution, and optical microscopy, such as fluorescence recovery after photobleaching measurements (FRAP), in addition to electrochemistry techniques (cyclic voltammetry (CV) and electrochemical impedance spectroscopy (EIS)). The advantages of this biomembrane-sensing platform are discussed for research and applications.

Grafting Commercial Surfactants (Brij, CiEj) and PEG to Electrodes via Aryldiazonium Salts.

Grafting commercial surfactants appears to be a simple way to modify electrodes and conducting interfaces, avoiding the synthesis of complex organic molecules. A new surface functionalization route is presented to build surfactant coatings with monolayer thickness grafting molecules considered as nonreactive. A monolayer of -SO2Cl functions (from a p-benzenesulfonyl chloride) was first electrografted. It showed a high reactivity toward weak nucleophiles commonly found on surfactant end-moieties such as hydroxyl groups (-OH), and it was used to covalently graft the following: (1) nonionic diblock oligomers (Brij or CiEj, CxH2x + (OCH2CH2)nOH with x = 16 and n = 23 for Brij58, x = 16 and n = 10 for Brij C10, and x = 16 and n = 2 for Brij52); (2) poly(ethylene glycol) (PEG) short chains (PEO9 for (OCH2CH2)nOH with n = 9) and mixed formula. The surface modification due to these molecular coatings was investigated in terms of wetting properties and interfacial electrochemistry characteristics (charge transfer resistivity, capacity, and ions dynamics). Built on flat and transparent thin chromium films, Brij and PEO mixed coatings have been proven to be promising coatings for electrochemical biosensor application such as for stabilizing a partially tethered supported biomimetic membrane.